Minicycline LB Capsule is a novel antimicrobial combination product containing doxycycline 100mg and 5 million spores of Lactobacillus. This unique blend offers enhanced efficacy and improved gut health by leveraging the synergistic effects of a broad-spectrum antibiotic and a probiotic. Doxycycline, a tetracycline-class antibiotic, exhibits potent antimicrobial activity against a wide range of bacteria, including gram-positive and gram-negative organisms, as well as certain atypical pathogens. Lactobacillus, a well-established probiotic, promotes a healthy gut microbiome by colonizing the intestinal tract and producing beneficial metabolites. The combination of doxycycline and Lactobacillus in Minicycline LB Capsule may facilitate more effective treatment of various infections, such as respiratory, urinary, and skin infections, while also supporting restoration of the gut-brain axis and overall immune function. By targeting both the pathogen and the host's microbiome, Minicycline LB Capsule may provide a more comprehensive therapeutic approach to infectious diseases.